WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that the Dana-Farber/Harvard Cancer Center (DF/HCC) has implemented Phase Forward’s InForm™ Electronic Data Capture (EDC) product for a 500-subject pediatric acute lymphoblastic leukemia (ALL) study.
